CD8+T-cell targeted peptide epitope vaccine (Emergex)

N/A

Report date: 2025/01/26 19:36:40

Base Information

Drug NameCD8+T-cell targeted peptide epitope vaccine (Emergex)
Drug Alias NameT-cell targeted peptide epitope vaccine (Emergex)
ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsChikungunya Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGylden Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGylden Pharma Ltd
Inactive CompaniesN/A
Active IndicationsChikungunya Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A